The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake.

Thornton-Jones, Zoë D; Kennett, Guy A; Benwell, Karen R; Revell, Dean F; Misra, Anil; Sellwood, Daniel M; Vickers, Steven P; Clifton, Pete

File(s) not publicly available

The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake.

journal contribution

posted on 2023-06-07, 18:58 authored by Zoë D Thornton-Jones, Guy A Kennett, Karen R Benwell, Dean F Revell, Anil Misra, Daniel M Sellwood, Steven P Vickers, Pete CliftonPete Clifton

No description supplied

History

Publication status

Published

Journal

Pharmacology Biochemistry and Behavior

ISSN

0091-3057

Publisher

Elsevier

External DOI

https://doi.org/10.1016/j.pbb.2006.06.001

Volume

84

Page range

353-359

Department affiliated with

Psychology Publications

Full text available

No

Peer reviewed?

Yes

Legacy Posted Date

2012-02-06

File(s) not publicly available

The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake.

History

Publication status

Journal

ISSN

Publisher

External DOI

Volume

Page range

Department affiliated with

Full text available

Peer reviewed?

Legacy Posted Date

Usage metrics

Categories

Keywords

Licence

Exports